Sequences

Sample result

SIINFEKL, an exact peptide

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

2,028 publications in 1,357 families match these filters.

  1. T-CELL BASED IMMUNOTHERAPY

    ACADEMISCH ZIEKENHUIS LEIDEN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  2. HIGH AFFINITY T CELL RECEPTORS AND USES THEREOF

    HUTCHINSON FRED CANCER RES

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  3. PLASMID CONSTRUCTS FOR HETEROLOGOUS PROTEIN EXPRESSION AND METHODS OF USE

    ONCOSEC MEDICAL INCORPORATED

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   18 SIINFEKL 25
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  4. US 10238731-B22019-03-26

    Chikagunya virus RNA vaccines

    ModernaTX, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 27 to 34. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   27 SIINFEKL 34
    

    8 of 8 identical, no gaps.

  5. EP 3458096-A12019-03-27

    T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

    CUE BIOPHARMA INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  6. US 10253097-B22019-04-09

    Isolated antibody

    Mayo Foundation for Medical Education and Research

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  7. COMBINATION THERAPY FOR CANCER

    MERCK PATENT GMBH

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  8. RNA FOR CANCER THERAPY

    CUREVAC AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  9. US 10265416-B22019-04-23

    Compositions for generation of immune tolerance to specific antigens

    Ecole Polytechnique Federale de Lausanna (EPFL)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 8 to 15. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    8 SIINFEKL 15
    

    8 of 8 identical, no gaps.

  10. US 10266847-B22019-04-23

    Methods of delivering a pseudotyped lentivirus

    CALIFORNIA INSTITUTE OF TECHNOLOGY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. EP 3471778-A22019-04-24

    COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

    UNIV MICHIGAN REGENTS

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 4 to 11. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    4 SIINFEKL 11
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  12. EP 3472193-A12019-04-24

    CIRCULAR RNAS AND THEIR USE IN IMMUNOMODULATION

    UNIV LELAND STANFORD JUNIOR

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  13. JP 2019511483-A2019-04-25

    STING ACTIVATING NANOVACCINE FOR IMMUNOTHERAPY

    THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  14. TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1

    FORTY SEVEN INC

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  15. EP 3475434-A22019-05-01

    SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION

    NANTCELL INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 294 to 301. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   294 SIINFEKL 301
    

    8 of 8 identical, no gaps.

  16. METHODS FOR PRODUCING A MHC MULTIMER

    STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. JP 2019511905-A2019-05-09

    COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY

    WASHINGTON UNIVERSITY

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 62/292046.

  18. EP 3483240-A12019-05-15

    DETERGENT COMPOSITION COMPRISING MODIFIED PROTEINS

    PROCTER & GAMBLE

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  19. JP 2019512230-A2019-05-16

    GITR ANTIBODIES, METHODS, AND USES

    JANSSEN BIOTECH INC,CAM HOLLAND,JOHN KEHOE,DANIEL VILLAREAL, MANUEL ALEJANDRO SEPULVEDA,LINDA SNYDER

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  20. NON-GENETIC MODIFICATION OF ENVELOPED VIRUSES

    Valo Therapeutics Oy

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 6 to 13. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    6 SIINFEKL 13
    

    8 of 8 identical, no gaps.

  21. MODIFIED VSV-G AND VACCINES THEREOF

    UNIVERSITE CATHOLIQUE DE LOUVAIN

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 236 to 243. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   236 SIINFEKL 243
    

    8 of 8 identical, no gaps.

  22. EP 3484448-A12019-05-22

    ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME

    HARVARD COLLEGE

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  23. JP 2019513021-A2019-05-23

    Sequence Arrangements And Sequences For Neoepitope Presentation

    NantOmics

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 294 to 301. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   294 SIINFEKL 301
    

    8 of 8 identical, no gaps.

  24. EP 3491009-A12019-06-05

    PROTEIN EXPRESSION ENHANCER SEQUENCES AND USE THEREOF

    ADURO BIOTECH INC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  25. EP 3492098-A12019-06-05

    IMMUNE ADJUVANT FOR CANCER

    ADVANCED INNOVATION DEV CO LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  26. Method for Generation of Cytotoxic T Lymphocytes and Use Thereof

    ImmunoMax Co., Ltd

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  27. EP 3496746-A12019-06-19

    COMPOSITIONS AND METHODS FOR MODULATING LAIR SIGNAL TRANSDUCTION

    NEXTCURE INC

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 6

    Grouped by a shared priority claim, US 62/370334.

  28. JP 2019516792-A2019-06-20

    PEPTIDE EXCHANGE SYSTEM AND METHOD

    MBL INTERNATIONAL CORP

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  29. JP 2019517271-A2019-06-24

    The core domain of annexins and uses thereof in antigen delivery and vaccination

    Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 449 to 456. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   449 SIINFEKL 456
    

    8 of 8 identical, no gaps.

  30. US 10328146-B22019-06-25

    Contructs for enhancing immune responses

    THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  31. US 10329338-B22019-06-25

    Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon

    The Regents of the University of Colorado

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  32. IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF

    ADVAXIS, INC

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 8, hit 193 to 200. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   193 SIINFEKL 200
    

    8 of 8 identical, no gaps.

    Family of 6

    Grouped by a shared priority claim, US 62/428515.

  33. PEPTIDE EXCHANGE PROTEIN

    CAMBRIDGE ENTPR LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  34. WO 2019151392-A2019-08-08

    A method of antigen-specific modulating of the expression of MHC

    TOHOKU UNIVERSITY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  35. US 10377988-B22019-08-13

    Cytokine receptor genes and the use thereof to enhance therapy

    MUSC FOUNDATION FOR RESEARCH DEVELOPMENT

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  36. JP 2019522465-A2019-08-15

    T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

    Ronald D Seidel,Rodolfo J Chaparro

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 21 to 28. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   21 SIINFEKL 28
    

    8 of 8 identical, no gaps.

  37. JP 2019522486-A2019-08-15

    ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME

    PRESIDENT AND FELLOWS OF HARVARD COLLEGE

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  38. US 10385120-B22019-08-20

    Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination

    Commissariat a l'Energie Atomique

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  39. US 10386367-B22019-08-20

    Method for producing an examination reagent and kit for analysing a T-cell frequency

    JACOBS UNIVERSITY BREMEN GGMBH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  40. JP 2019522971-A2019-08-22

    ARTICLES COMPRISING A SILK POLYPEPTIDE FOR ANTIGEN DELIVERY

    AMSilk GmbH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 580 to 587. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   580 SIINFEKL 587
    

    8 of 8 identical, no gaps.

  41. JP 2019522991-A2019-08-22

    LISTERIA-BASED IMMUNOGENIC COMPOSITIONS COMPRISING WILMS TUMOR PROTEIN ANTIGENS AND METHODS OF USE THEREOF

    Advaxis Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 3 to 10. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    3 SIINFEKL 10
    

    8 of 8 identical, no gaps.

  42. US 10400024-B22019-09-03

    Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing peptides

    SANQUIN REAGENTS B.V.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  43. FUSION PROTEINS FOR THE OUTER MEMBRANE VESICLE (OMV) DELIVERY OF HETEROLOGOUS POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS THEREOF

    BIOMVIS SRL

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 310 to 317. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   310 SIINFEKL 317
    

    8 of 8 identical, no gaps.

  44. COMPOSITIONS AND METHODS FOR EVALUATING ATTENUATION AND INFECTIVITY OF LISTERIA STRAINS

    ADVAXIS INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 8, hit 3 to 10. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    3 SIINFEKL 10
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  45. JP 2019526556-A2019-09-19

    RNA for cancer therapy

    CureVac AG

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  46. US 10421945-B22019-09-24

    Agents and methods to elicit anti-tumor immune response

    The Trustees of Columbia University in the City of New York and The United States of America, as Represented by the Secretary, Department of Health and Human Service

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  47. EP 3541417-A12019-09-25

    COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

    PRIMEVAX IMMUNO ONCOLOGY INC

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  48. US 10434133-B22019-10-08

    Inflammation-suppressing composition including peptide

    KIRIN HOLDINGS KABUSHIKI KAISHA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  49. JP 2019528072-A2019-10-10

    FUSION PEPTIDES WITH ANTIGENS LINKED TO SHORT FRAGMENTS OF INVARIANT CHAIN (CD74)

    GlaxoSmithKline Biologicals S A,University of Copenhagen

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, GB 1614387.7.

  50. CHIMERIC NOTCH RECEPTORS

    STICHTING SANQUIN BLOEDVOORZIENING

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.